WorldCat Identities

Farkouh, Michael E.

Overview
Works: 22 works in 22 publications in 2 languages and 35 library holdings
Roles: Other, Contributor, Author
Publication Timeline
.
Most widely held works by Michael E Farkouh
Improving the clinical examination for a low ankle-brachial index( )

1 edition published in 2011 in English and held by 2 WorldCat member libraries worldwide

The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis by Claudia Calcagno( )

1 edition published in 2013 in English and held by 2 WorldCat member libraries worldwide

Age and sex-specific associations of anthropometric measures of adiposity with blood pressure and hypertension in India: a cross-sectional study by Kevin Y Taing( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery by Louai Razzouk( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction by Lisandro D Colantonio( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction by Idan Roifman( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Food as Medicine for Secondary Prevention of Cardiovascular Events Following an Acute Coronary Syndrome by Vijayapraveena Paruchuri( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus by Gennaro Giustino( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Old Drugs for New Indications in Cardiovascular Medicine by Yaron Arbel( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective? by Bijan J Borah( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease by Wassim Mosleh( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

Background: Numerous randomised trials have compared coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for patients with coronary artery disease. However, no studies have been powered to detect a difference in mortality between the revascularisation strategies. Methods: We did a systematic review up to July 19, 2017, to identify randomised clinical trials comparing CABG with PCI using stents. Eligible studies included patients with multivessel or left main coronary artery disease who did not present with acute myocardial infarction, did PCI with stents (bare-metal or drug-eluting), and had more than 1 year of follow-up for all-cause mortality. In a collaborative, pooled analysis of individual patient data from the identified trials, we estimated all-cause mortality up to 5 years using Kaplan-Meier analyses and compared PCI with CABG using a random-effects Cox proportional-hazards model stratified by trial. Consistency of treatment effect was explored in subgroup analyses, with subgroups defined according to baseline clinical and anatomical characteristics. Findings: We included 11 randomised trials involving 11 518 patients selected by heart teams who were assigned to PCI (n=5753) or to CABG (n=5765). 976 patients died over a mean follow-up of 3·8 years (SD 1·4). Mean Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score was 26·0 (SD 9·5), with 1798 (22·1%) of 8138 patients having a SYNTAX score of 33 or higher. 5 year all-cause mortality was 11·2% after PCI and 9·2% after CABG (hazard ratio [HR] 1·20, 95% CI 1·06-1·37; p=0·0038). 5 year all-cause mortality was significantly different between the interventions in patients with multivessel disease (11·5% after PCI vs 8·9% after CABG; HR 1·28, 95% CI 1·09-1·49; p=0·0019), including in those with diabetes (15·5% vs 10·0%; 1·48, 1·19-1·84; p=0·0004), but not in those without diabetes (8·7% vs 8·0%; 1·08, 0·86-1·36; p=0·49). SYNTAX score had a significant effect on the difference between the interventions in multivessel disease. 5 year all-cause mortality was similar between the interventions in patients with left main disease (10·7% after PCI vs 10·5% after CABG; 1·07, 0·87-1·33; p=0·52), regardless of diabetes status and SYNTAX score. Interpretation: CABG had a mortality benefit over PCI in patients with multivessel disease, particularly those with diabetes and higher coronary complexity. No benefit for CABG over PCI was seen in patients with left main disease. Longer follow-up is needed to better define mortality differences between the revascularisation strategies. Funding: None
Stosowanie niesteroidowych leków przeciwzapalnych u chorych z przewlekłymi zespołami bólowymi : co wynika z badań klinicznych by Michael E Farkouh( )

1 edition published in 2013 in Polish and held by 1 WorldCat member library worldwide

Getting to the heart of the matter : a trialist's approach to the use of nonsteroidal anti-inflammatory drugs for patients with chronic pain syndromes by Michael E Farkouh( )

1 edition published in 2013 in English and held by 1 WorldCat member library worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.97 (from 0.88 for Mortality ... to 0.99 for Stosowanie ...)

Languages
English (16)

Polish (4)